Search Results - Brescia C
- Showing 1 - 1 results of 1
-
1
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study by Megna M, Ruggiero A, Tommasino N, Brescia C, Martora F, Cacciapuoti S, Potestio L
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book